Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | neuropeptide receptor A26 | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Echinococcus multilocularis | neuropeptide receptor A26 | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Echinococcus multilocularis | neuropeptide s receptor | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Schistosoma japonicum | IPR000276,Rhodopsin-like GPCR superfamily,domain-containing | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Echinococcus granulosus | neuropeptide s receptor | Get druggable targets OG5_136011 | All targets in OG5_136011 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | oligopeptidase b | 0.0133 | 0.0469 | 0.1499 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0021 | 0.0021 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0133 | 0.0469 | 0.1499 |
Mycobacterium tuberculosis | Probable peptidase | 0.0133 | 0.0469 | 0.5 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0563 | 0.3129 | 1 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.1674 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0133 | 0.0469 | 0.1499 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0133 | 0.0469 | 1 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0133 | 0.0469 | 0.5 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0563 | 0.3129 | 0.2791 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0133 | 0.0469 | 0.5 |
Brugia malayi | hypothetical protein | 0.043 | 0.2308 | 0.2308 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0133 | 0.0469 | 0.0469 |
Trypanosoma brucei | serine peptidase, clan SC, family S9A-like protein | 0.0133 | 0.0469 | 0.1499 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0563 | 0.3129 | 1 |
Trypanosoma cruzi | serine peptidase, clan SC, family S9A-like protein, putative | 0.0133 | 0.0469 | 0.1499 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.1674 | 1 | 1 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0563 | 0.3129 | 0.2791 |
Loa Loa (eye worm) | hypothetical protein | 0.043 | 0.2308 | 0.2308 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0133 | 0.0469 | 0.5 |
Leishmania major | oligopeptidase B-like protein,serine peptidase, clan SC, family S9A-like protein | 0.0133 | 0.0469 | 0.1499 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0133 | 0.0469 | 0.0469 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0133 | 0.0469 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0133 | 0.0469 | 0.5 |
Trypanosoma cruzi | oligopeptidase b | 0.0133 | 0.0469 | 0.1499 |
Trypanosoma brucei | Alpha/beta hydrolase domain-containing protein | 0.0133 | 0.0469 | 0.1499 |
Echinococcus granulosus | neuropeptide s receptor | 0.0558 | 0.3101 | 0.2762 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.1674 | 1 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0563 | 0.3129 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0133 | 0.0469 | 0.0469 |
Brugia malayi | Cytochrome P450 family protein | 0.012 | 0.0391 | 0.0391 |
Plasmodium vivax | hypothetical protein, conserved | 0.0133 | 0.0469 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0021 | 0.0021 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0133 | 0.0469 | 0.5 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0133 | 0.0469 | 0.1499 |
Trypanosoma brucei | prolyl oligopeptidase, putative | 0.0133 | 0.0469 | 0.1499 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0469 | 0.0469 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.012 | 0.0391 | 0.0391 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0563 | 0.3129 | 0.3129 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0133 | 0.0469 | 0.5 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0563 | 0.3129 | 1 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0133 | 0.0469 | 0.5 |
Trichomonas vaginalis | Clan SC, family S9, acylaminoacyl-peptidase-like serine peptidase | 0.0133 | 0.0469 | 0.5 |
Leishmania major | oligopeptidase b | 0.0133 | 0.0469 | 0.1499 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.1674 | 1 | 1 |
Giardia lamblia | Alanyl dipeptidyl peptidase | 0.0133 | 0.0469 | 0.5 |
Trypanosoma cruzi | oligopeptidase B-like protein, putative | 0.0133 | 0.0469 | 0.1499 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0021 | 0.0021 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0563 | 0.3129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0469 | 0.0469 |
Entamoeba histolytica | dipeptidyl-peptidase, putative | 0.0133 | 0.0469 | 0.5 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0133 | 0.0469 | 0.0469 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.1674 | 1 | 1 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0563 | 0.3129 | 0.2791 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0563 | 0.3129 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0558 | 0.3101 | 0.2762 |
Trypanosoma brucei | oligopeptidase b | 0.0133 | 0.0469 | 0.1499 |
Plasmodium falciparum | peptidase, putative | 0.0133 | 0.0469 | 0.5 |
Mycobacterium tuberculosis | Probable protease II PtrBb [second part] (oligopeptidase B) | 0.0133 | 0.0469 | 0.5 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0558 | 0.3101 | 0.2762 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0021 | 0.0021 |
Entamoeba histolytica | prolyl oligopeptidase family protein | 0.0133 | 0.0469 | 0.5 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0558 | 0.3101 | 0.2762 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0133 | 0.0469 | 0.1499 |
Trypanosoma brucei | prolyl endopeptidase | 0.0133 | 0.0469 | 0.1499 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0469 | 0.0469 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.5119 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.